NASDAQ:ABOS | Cash Flow Statement | Acumen Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$32.72M
2026-03-31-$20.74M-$24.13M-$13.81M$35.74M
2025-12-31-$25.14M-$19.1M$26.25M$2,000.00
2025-09-30-$26.45M
2025-06-30-$40.95M
2025-03-31-$28.8M-$34.12M$28.69M-$36,000.00
2024-12-31-$37.15M-$27.22M$29.66M-$9,000.00
2024-09-30-$29.77M
2024-06-30-$20.54M
2024-03-31-$14.87M-$17.86M-$9.2M$7.11M
2023-12-31-$16.5M-$8.31M-$48.81M$29.13M
2023-09-30-$12.96M
2023-06-30-$11.61M
2023-03-31-$11.31M-$10.18M-$41.93M$0.00
2022-12-31-$12.87M-$11.2M-$20.42M$4.18M
2022-09-30-$10.71M
2022-06-30-$10.15M
2022-03-31-$9.13M-$8.3M-$5.1M
2021-12-31-$8.35M-$3.64M-$10.01M$10,000.00
2021-09-30-$3.9M
2021-06-30-$61.36M
2021-03-31-$27M-$2.37M
2020-12-31-$755,000.00-$2.86M
2020-09-30-$2.49M
2020-06-30-$2.04M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$121.34M-$115.54M$133.93M-$34,000.00
2024-12-31-$102.33M-$86.22M$48.03M$6.93M
2023-12-31-$52.37M-$43.06M-$171.67M$151.75M
2022-12-31-$42.86M-$35.15M$39.19M$3.91M
2021-12-31-$100.61M-$17.96M-$104.12M$200.47M
2020-12-31-$7.33M-$7.45M$44.68M